Study of Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer (Ovarian Spore)
- Even if tumor sample is collected, the participant is under no obligation to
participate in the vaccine study.
- Participants will have their regularly planned surgery as described by their surgeon.
During the surgery, tumor samples will be collected. We will only collect tumor that is
not needed and could otherwise be thrown away.
- The tumor samples will be frozen and placed in storage for up to two years.
Intervention Model: Single Group Assignment, Masking: Open Label
To collect patient tumor samples that could possibly be used in a subsequent clinical vaccine trial (DF/HCC protocol 07-380).
David Avigan, MD
Beth Israel Deaconess Medical Center
United States: Institutional Review Board
|Beth Israel Deaconess Medical Center||Boston, Massachusetts 02215|
|Dana-Farber Cancer Institute||Boston, Massachusetts 02115|
|Massachusetts General Hospital||Boston, Massachusetts 02114-2617|
|Brigham & Women's Hospital||Boston, Massachusetts 02115|